Zepbound

5 Stories

FDA Approves First Medication as a Sleep Apnea Treatment

Next question will be about Medicare and other insurance coverage

(Newser) - The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound. The decision could lead to expanded insurance coverage of the medication, CNBC reports; plans often don't include weight-loss drugs. Eli Lilly, the manufacturer, said Friday that Zepbound should be used...

Eli Lilly to Test Weight-Loss Drugs on Addiction

Company's CEO indicates they'll start testing Zepbound for other forms of treatment in 2025

(Newser) - Earlier this week, Eli Lilly announced it was teaming up with telehealth provider Ro to boost access to Zepbound, one of its weight-loss medications. Now, the pharmaceuticals giant is revealing more plans for its blockbuster drug, noting it wants to start testing Zepbound in 2025 as a treatment not only...

Eli Lilly: Zepbound Worked Wonders for Sleep Apnea

Its weight-loss drug was found to reduce sleep events, the company announced

(Newser) - Eli Lilly's Zepbound doesn't just lead to weight loss, per the company. A 52-week study found a reduction in obstructive sleep apnea in adults with obesity, the company said Wednesday. Obstructive sleep apnea is a condition in which an upper airway blockage during sleep restricts airflow. People with...

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat
It's Forecast to Be Bestselling
Drug Ever. Now, a Big Caveat
IN CASE YOU MISSED IT
Dec 16, 2023 6:30 AM CST

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat

Study results show patients who went off Zepbound for a year regained half of weight lost

(Newser) - The full results from Eli Lilly's study of its newly approved weight-loss drug Zepbound serve as a splash of cold water in the face of those who believed a few dozen weekly injections would cause pounds to melt off and stay off. The FDA approved Zepbound, with the active...

It's the 'Most Efficacious Drug Ever Approved for Obesity'

FDA approves Zepbound, new version of diabetes drug Mounjaro

(Newser) - A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, US regulators announced Wednesday. NBC News reports the FDA approved Eli Lilly's Zepbound, or tirzepatide, a drug that helped dieters lose 22.5% of their body weight (or 52 pounds) in its phase...

5 Stories